Esperion Therapeutics
ESPR
ESPR
151 hedge funds and large institutions have $1.38B invested in Esperion Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 70 increasing their positions, 26 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $1.38B → $1.38B (+$5.87M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
151
Holding in Top 10
3
Calls
$139M
Puts
$61.6M
Top Buyers
| 1 | +$103M | |
| 2 | +$25.5M | |
| 3 | +$24M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$18.2M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$12.6M |
Top Sellers
| 1 | -$50.1M | |
| 2 | -$34.1M | |
| 3 | -$14.7M | |
| 4 |
JP Morgan Chase
New York
|
-$9.97M |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$8.75M |